Live
- ‘Elated’ Gautam Gambhir thanks Jay Shah following his appointment as head coach
- K’taka govt wants to change Ramanagara’s name as it has ‘Ram’ in it: BJP
- Rajasthan govt should act tough against illegal mining: Sachin Pilot
- Manipur tribals' body call 12-hr shut down to protest arrest of 5 village volunteers
- WhatsApp's new feature to help users stay safe in group messaging
- MP court sends terror suspect Faizan Sheikh to 14 days judicial custody
- Amarwara bypoll: A battle of prestige for BJP & Congress
- Trump vows to stop outsourcing, if elected President
- Jay Shah sends farewell message to Dravid as Gambhir is appointed as head coach
- ED uncovers scams involving Himachal Pradesh Chief Minister's close associates: Sources
Centre approves nasal vaccine
Centre approves nasal vaccine
Highlights
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform on Friday evening, official sources said.
New Delhi: Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform on Friday evening, official sources said.
The needle-free vaccine will be available at private hospitals as of now and can be administered as a precaution dose to adults who have been vaccinated with two doses of either Covishield or Covaxin. It is likely to be rolled out in the national Covid vaccination programme soon, they said. The ministry's approval for the intranasal vaccine as a booster comes amid a spurt in Covid cases in China and some other countries.
Next Story
ADVERTISEMENT
